Cerevel Therapeutics Holdings, Inc.

CEREDelisted Aug 1, 2024

Industry: Pharmaceutical Preparations
SEC CIK: 0001805387

SEC filings (opens in a new tab)

Cerevel Therapeutics Holdings, Inc. was delisted on Aug 1, 2024; its insiders filed their last Form 4 on Aug 5, 2024; 231 institutions reported holding it in 13F filings for Q2 2024, worth $6.42B in total; Soros Fund Management was the only superinvestor holding it.

Q4 2021 vs. Q3 2021

How the institutions holding Cerevel Therapeutics Holdings, Inc. changed between Q3 2021 and Q4 2021.

All holders in Q4 2021 All holders in Q3 2021

13F holders of CERE: Q3 2021 compared with Q4 2021
Measure	Q3 2021	Of which not filed for Q4 2021	Q4 2021	Change
Holders	94	1	107	+14
Shares	119.1M	33	118.6M	−518.3K (−0.4%)
Value	$3.51B	$0	$3.84B	+$331.0M (+9.4%)

1 institution that held it in Q3 2021 haven't filed for Q4 2021 yet. Not filing isn't selling, so the changes leave them out.

New holders (27)

Institutions that held Cerevel Therapeutics Holdings, Inc. at the end of Q4 2021 but not at the end of Q3 2021.

Institutions new to CERE in Q4 2021
Institution	Shares	Value	% of portfolio
Lord, Abbett & Co. LLC	729,165	$23.6M	0.05%
Candriam Luxembourg S.C.A.	105,599	$3.42M	0.02%
Tekla Capital Management LLC	41,003	$1.33M	0.04%
Toronto Dominion Bank	38,051	$1.23M	0.00%
HRT Financial LP	29,088	$943.0K	0.01%
Allianz Asset Management GmbH	20,260	$657.0K	0.00%
Putnam Investments LLC	16,239	$527.0K	0.00%
AlphaCrest Capital Management LLC	10,328	$335.0K	0.01%
Handelsbanken Fonder AB	10,300	$334.0K	0.00%
ProShare Advisors LLC	8,901	$289.0K	0.00%
Boulder Hill Capital Management LP	8,900	$289.0K	0.28%
Schonfeld Strategic Advisors LLC	8,546	$277.0K	0.00%
Victory Capital Management Inc	7,888	$256.0K	0.00%
DuPont Capital Management Corp	3,608	$117.0K	0.00%
Meeder Asset Management Inc	2,782	$90.0K	0.01%
Nisa Investment Advisors, LLC	2,196	$57.0K	0.00%
Macquarie Group Ltd	665	$22.0K	0.00%
Leonteq Securities AG	521	$16.9K	0.00%
Covestor Ltd	185	$6.00K	0.01%
Toth Financial Advisory Corp	30	$1.00K	0.00%
Captrust Financial Advisors	34	$1.00K	0.00%
Tarbox Family Office, Inc.	36	$1.00K	0.00%
Ellevest, Inc.	40	$1.00K	0.00%
Advisor Group Holdings, Inc.	31	$1.00K	0.00%
Fortitude Advisory Group L.L.C.	32	$1.00K	0.00%
Parallel Advisors, LLC	9	$0	0.00%
FNY Investment Advisers, LLC	15	$0	0.00%

Sold out (13)

Institutions that held Cerevel Therapeutics Holdings, Inc. at the end of Q3 2021 and filed for Q4 2021 without it.

Institutions that sold out of CERE in Q4 2021
Institution	Shares, Q3 2021	Value, Q3 2021
Alyeska Investment Group, L.P.	424,767	$12.5M
Healthcare of Ontario Pension Plan Trust Fund	194,400	$5.74M
Point72 Asset Management, L.P.	141,400	$4.17M
Ikarian Capital, LLC	53,370	$1.57M
LMR Partners LLP	50,000	$1.48M
Brookfield Asset Management Inc.	43,204	$1.27M
Gsa Capital Partners LLP	25,942	$765.0K
Bellwether Advisors, LLC	17,197	$507.0K
Prudential Financial Inc	10,500	$310.0K
Virtu Financial LLC	8,525	$251.0K
Federation des caisses Desjardins du Quebec	200	$5.90K
JFS Wealth Advisors, LLC	100	$3.00K
TCI Wealth Advisors, Inc.	104	$3.00K

Not filed for Q4 2021 yet (1)

Institutions that held Cerevel Therapeutics Holdings, Inc. at the end of Q3 2021 and haven't filed a 13F for Q4 2021. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding CERE in Q3 2021 that haven't filed for Q4 2021
Institution	Shares, Q3 2021	Value, Q3 2021
Berman Capital Advisors, LLC	33	$0